These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10331044)

  • 21. Study of the cyclosporine concentration at 2 hours in stable renal transplant patients and relation to body mass index.
    Hortal L; Fernández A; Losada A; Lorenzo M; Baamonde E; Plaza C; Gallego R; Vega N; Palop L
    Transplant Proc; 2001; 33(7-8):3110-1. PubMed ID: 11750337
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclosporine increases endothelin-1 plasma levels in renal transplant recipients.
    Cauduro RL; Costa C; Lhulier F; Garcia RG; Cabral RD; Gonçalves LE; Manfro RC
    Transplant Proc; 2004 May; 36(4):880-1. PubMed ID: 15194301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of lymphocyte cyclosporine levels in transplant patients.
    Masri MA; Barbari A; Stephan A; Rizk S; Kilany H; Kamel G
    Transplant Proc; 1998 Nov; 30(7):3561-2. PubMed ID: 9838559
    [No Abstract]   [Full Text] [Related]  

  • 24. Population pharmacokinetics of cyclosporine in kidney transplant patients.
    Porta B; Pérez-Ruixo JJ; Górriz JL; Crespo JF; Sancho A; Pallardó LM; Jiménez NV
    Transplant Proc; 1999 Sep; 31(6):2246-7. PubMed ID: 10500561
    [No Abstract]   [Full Text] [Related]  

  • 25. Time-dependent difference of the 12-hour trough levels of cyclosporine in renal transplant recipients with sandimmune capsule.
    To H; Haba T; Uchida K; Fujimura A; Kobayashi E
    Transplant Proc; 2000 Feb; 32(1):221-2. PubMed ID: 10701028
    [No Abstract]   [Full Text] [Related]  

  • 26. Study of neoral kinetics in adult renal transplantation treated with diltiazem.
    Mezzano S; Flores C; Ardiles L; Foradori A; Elberg A
    Transplant Proc; 1998 Aug; 30(5):1660-2. PubMed ID: 9723232
    [No Abstract]   [Full Text] [Related]  

  • 27. Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients.
    Dudley CR;
    Transplant Proc; 2001; 33(1-2):1034-5. PubMed ID: 11267179
    [No Abstract]   [Full Text] [Related]  

  • 28. Endothelin-1 plasma levels and hypertension in cyclosporine-treated renal transplant patients.
    Cauduro RL; Costa C; Lhulier F; Garcia RG; Cabral RD; Gonçalves LF; Manfro RC
    Clin Transplant; 2005 Aug; 19(4):470-4. PubMed ID: 16008590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conversion from Sandimmune to Neoral in renal transplant recipients: two-year experience.
    Wilczek HE; Akesson P; Warholm C
    Transplant Proc; 1998 Aug; 30(5):1753-5. PubMed ID: 9723267
    [No Abstract]   [Full Text] [Related]  

  • 30. High QT dispersion in tacrolimus-treated kidney transplant recipients.
    Gerhardt U; Suwelack B; Pawolka A; Hohage H
    Transplant Proc; 2001 May; 33(3):2148-50. PubMed ID: 11377482
    [No Abstract]   [Full Text] [Related]  

  • 31. Cyclosporine trough levels in diabetic and nondiabetic renal transplant patients.
    Wadhawan S; Jauhari H; Singh S
    Transplant Proc; 2000 Nov; 32(7):1683-4. PubMed ID: 11119891
    [No Abstract]   [Full Text] [Related]  

  • 32. Experience with clinical use of Sandimmun Neoral in renal transplant patients.
    Min ZL; Zhao M; Zhu YH; Qi J; Wang LM; Wang YW
    Transplant Proc; 1996 Jun; 28(3):1356-7. PubMed ID: 8658692
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetic study of twice vs thrice daily dosing of Sandimmun Neoral in pediatric renal transplant patients.
    Papachristou F; Gakis D; Sotiriou I; Liatsis I; Takoudas D; Antoniadis A
    Transplant Proc; 1998 Aug; 30(5):1988-90. PubMed ID: 9723363
    [No Abstract]   [Full Text] [Related]  

  • 34. Decreased nephrotoxicity after the use of a microemulsion formulation of cyclosporine A compared to conventional solution.
    Ahlmén J; Sundberg A; Gustavsson A; Strömbom U
    Transplant Proc; 1995 Dec; 27(6):3432-3. PubMed ID: 8540036
    [No Abstract]   [Full Text] [Related]  

  • 35. Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients--a comment.
    Zehngawa W
    Eur J Clin Pharmacol; 2005 Jun; 61(4):317. PubMed ID: 15891875
    [No Abstract]   [Full Text] [Related]  

  • 36. Interactions of cyclosporin A and amlodipine: blood cyclosporin A levels, hypertension and kidney function.
    Schrama YC; Koomans HA
    J Hypertens Suppl; 1998 Sep; 16(4):S33-8. PubMed ID: 9817190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of cyclosporine therapy with abbreviated area under the curve method in renal transplant.
    Yang WC; Chen YF; King KL; Wu TH; Chen Hsu RY ; Tang JJ; Loong CC; Chou MH; Lin MF; Lui WY
    Transplant Proc; 2000 Nov; 32(7):1685-7. PubMed ID: 11119892
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of cyclosporin A on the level of big endothelin in patients one year after orthotopic heart transplantation.
    Kocík M; Málek I; Glagolicová A; Pirk J
    Transpl Int; 2004 Feb; 17(2):65-70. PubMed ID: 14634722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and renal function after conversion from standard to microemulsion formulation of cyclosporine in stable renal transplant patients.
    Gaspari F; Anedda MF; Signorini O; Amuchastegui SC; Perico N; Remuzzi G
    Transplant Proc; 1998 Aug; 30(5):1654-5. PubMed ID: 9723229
    [No Abstract]   [Full Text] [Related]  

  • 40. Ten years after: long-term effects of cyclosporine-based immunosuppression on renal allograft recipients.
    Kondo T; Kinukawa T; Takeuchi N; Hattori R; Ono Y; Matsuura O; Fujita T; Ohshima S
    Transplant Proc; 1998 Nov; 30(7):3530-2. PubMed ID: 9838546
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.